| Literature DB >> 35203840 |
Zijun Zhang1, Kai Cao1, Jiamin Liu1, Zhenyu Wei1, Xizhan Xu1, Qingfeng Liang1.
Abstract
Bacterial keratitis (BK) is the most common type of infectious keratitis. The spectrum of pathogenic bacteria and their susceptibility to antibiotics varied with the different regions. A meta-analysis was conducted to review the global culture rate, distribution, current trends, and drug susceptibility of isolates from BK over the past 20 years (2000-2020). Four databases were searched, and published date was limited between 2000 and 2020. Main key words were "bacterial keratitis", "culture results" and "drug resistance". Forty-two studies from twenty-one countries (35 cities) were included for meta-analysis. The overall positive culture rate was 47% (95%CI, 42-52%). Gram-positive cocci were the major type of bacteria (62%), followed by Gram-negative bacilli (30%), Gram-positive bacilli (5%), and Gram-negative cocci (5%). Staphylococcus spp. (41.4%), Pseudomonas spp. (17.0%), Streptococcus spp. (13.1%), Corynebacterium spp. (6.6%) and Moraxella spp. (4.1%) were the most common bacterial organism. The antibiotic resistance pattern analysis revealed that most Gram-positive cocci were susceptive to aminoglycoside (86%), followed by fluoroquinolone (81%) and cephalosporin (79%). Gram-negative bacilli were most sensitive to cephalosporin (96%) and fluoroquinolones (96%), followed by aminoglycoside (92%). In Gram-positive cocci, the susceptibility trends of fluoroquinolones were decreasing since 2010. Clinics should pay attention to the changing trends of pathogen distribution and their drug resistance pattern and should diagnose and choose sensitive antibiotics based on local data.Entities:
Keywords: antibiotic; bacteria; keratitis; microorganisms; susceptibility
Year: 2022 PMID: 35203840 PMCID: PMC8868051 DOI: 10.3390/antibiotics11020238
Source DB: PubMed Journal: Antibiotics (Basel) ISSN: 2079-6382
Figure 1The PRISMA flow chart of paper selection.
Characteristics of the studies included in the meta-analysis.
| Authors (Years) | Country | City | Study Period | Sample Size | Positive Rate (%) | Microbiological Profiles |
|---|---|---|---|---|---|---|
|
| ||||||
| Schaefer (2001) | Switzerland | Lausanne | 1997–1998 | 85 | 86 | |
| Saeed (2009) | Ireland | Dublin | 2001–2003 | 90 | 36 | |
| Orlans (2011) | UK | Oxford | 1999–2009 | 467 | 54 | Coagulase negative |
| Prokosch (2012) | Germany | Münster | 2002–2009 | 346 | 43 | |
| Otri (2013) | UK | Nottingham | 2007–2007 | 129 | 35 | |
| Tan (2017) | UK | Manchester | 2004–2015 | 4229 | 30 | Coagulase negative |
| Ferreira (2018) | Portugal | Porto | 2007–2015 | 235 | 38 | |
| Tavassoli (2019) | UK | Bristol | 2006–2017 | 2116 | 38 | Coagulase negative |
| Tena (2019) | Spain | Guadalajara | 2010–2016 | 298 | 65 | Coagulase |
|
| ||||||
| Capriotti (2010) | Sierra Leone | Freetown | 2005–2006 | 73 | 58 | |
|
| ||||||
| Sharma (2007) | India | Hyderabad | 2002–2002 | 170 | 62 | |
| Yilmaz (2007) | Turkey | Izmir | 1990–2005 | 620 | 28 | |
| Fong (2007) | China | Taipei | 1994–2005 | 272 | - | |
| Lavaju (2009) | Nepal | Dharan | 2007–2008 | 44 | 36 | |
| Feilmeier (2010) | Nepal | Kathmandu | 2006–2009 | 468 | 15 | |
| Dhakhwa (2012) | Nepal | Siddharthanagar | 2007 | 414 | 39 | |
| Lin (2012) | India | Madurai | 2006–2009 | 5221 | 21 | |
| Politis (2016) | Israel | Jerusalem | 2002–2014 | 943 | 44 | Coagulase-negative |
| Hsiao (2016) | China | Taoyuan | 2003–2012 | 2012 | 40 | |
| Aruljyothi (2016) | India | Madurai | 2011–2013 | 234 | 30 | |
| Lin (2017) | China | Guangzhou | 2009–2013 | 2973 | 12 | |
| Bagga (2018) | India | Hyderabad | 1991–2012 | 60 | 42 | |
| Mun (2019) | Korea | Seoul | 2007–2016 | 129 | 78 | Coagulase negative |
| Liu (2019) | China | Taipei | 2007–2016 | 363 | 51 | |
| Das (2019) | India | Hyderabad | 2007–2014 | 3981 | 29 | |
| Khor (2020) | Malaysia | Sarawak | 2010–2016 | 221 | 30 | |
|
| ||||||
| Hall (2004) | New Zealand | Christchurch | 1997–2001 | 87 | 59 | Coagulase negative |
| Ly (2006) | Australia | Sydney | 2002–2003 | 112 | 42 | Coagulase negative |
| Constantinou (2009) | Australia | Melbourne | 1998–2007 | 47 | 70 | |
| Pandita (2011) | New Zealand | Hamilton | 2007 | 265 | 65 | Coagulase negative |
| Watson (2019) | Australia | Sydney | 2016 | 224 | 75 | Coagulase negative |
|
| ||||||
| Alexandrakis (2000) | USA | Miami | 1990–1998 | 2920 | 50 | |
| Yeh (2006) | USA | Durham | 1997–2004 | 453 | 68 | Coagulase |
| Afshari (2008) | USA | Boston | 1999–2000 | 485 | 66 | Coagulase |
| Lichtinger (2012) | Canada | Toronto | 2000–2010 | 1701 | 53 | Coagulase |
| Hernandez-Camarena (2015) | Mexico | Mexico City | 2002–2011 | 1638 | 33 | |
| Sand (2015) | USA | Los angeles | 2008–2012 | 476 | 62 | Coagulase |
| Rossetto (2017) | USA | Miami | 1992–2015 | 107 | 58 | |
| Tam (2017) | Canada | Toronto | 2000–2015 | 2330 | 49 | Coagulase negative |
| Jin (2017) | USA | Houston | 2011–2015 | 96 | 62 | |
| Peng (2018) | USA | San Francisco | 1996–2015 | 2203 | 24 | |
| Termote (2018) | Canada | Vancouver | 2006–2011 | 281 | 75 | Coagulase negative |
Figure 2Analysis of positive rate of bacterial culture (38 studies).
Figure 3Positive rate of bacterial culture from corneal lesions in different regions.
Distribution of bacteria isolated from corneal lesions of bacterial keratitis.
| Organism | Isolates | Percentage (%) | 95%CI (%) |
|---|---|---|---|
|
|
|
|
|
|
| 5311 | 41.4 | 36.2~46.7 |
|
| 1913 | 13.1 | 10.9~15.7 |
|
| 18 | 3.8 | 2.4~6.0 |
|
| 41 | 2.5 | 1.8~3.3 |
|
| 12 | 1.6 | 0.9~2.8 |
|
| 10 | 1.3 | 0.7~2.4 |
|
| 7 | 0.8 | 0.3~1.6 |
|
| 6 | 0.8 | 0.4~1.7 |
|
| 2 | 0.7 | 0.2~2.9 |
|
|
|
|
|
|
| 2331 | 17.0 | 13.9~20.7 |
|
| 311 | 4.1 | 3.1~5.4 |
|
| 373 | 3.4 | 2.7~4.2 |
|
| 64 | 2.2 | 1.8~2.8 |
|
| 54 | 2.1 | 1.1~4.0 |
|
| 38 | 2.0 | 1.5~2.7 |
|
| 17 | 1.8 | 1.1~2.8 |
|
| 1 | 1.9 | 0.0~12.2 |
|
| 26 | 1.8 | 1.3~2.7 |
|
| 18 | 1.8 | 1.2~2.9 |
|
| 13 | 1.2 | 0.7~2.0 |
|
| 11 | 1.1 | 0.6~2.0 |
|
| 2 | 1.0 | 0.3~3.9 |
|
| 5 | 0.9 | 0.4~2.0 |
|
| 871 | 5.2 | 3.9~6.8 |
|
| 284 | 6.6 | 5.2~8.3 |
|
| 96 | 3.9 | 2.4~6.0 |
|
| 243 | 3.3 | 1.7~6.0 |
|
| 184 | 2.6 | 0.7~8.5 |
|
| 2 | 2.6 | 0.7~8.5 |
|
| 2 | 2.6 | 0.7~8.5 |
|
| 2 | 1.0 | 0.3~3.9 |
|
| 10 | 0.8 | 0.4~1.5 |
|
| 3 | 0.8 | 0.3~2.1 |
|
| 26 | 5.2 | 3.9~6.8 |
|
| 5 | 0.8 | 0.3~1.9 |
|
| 1891 | 11.9 | 9.3~15.1 |
Figure 4The changing trends of bacterial isolates from corneal lesions in 1990s–2020s.
Figure 5Results of drug susceptibility test of the strains isolated from corneal lesions.
Figure 6The changing trends of drug susceptibility in 1990s–2020s.
Databases searched in our study.
| Database Name | Endnote Importer Order | Number of References before Deduplication | Number of References after Deduplication (Removed) |
|---|---|---|---|
| Ovid Embase | 1 | 829 | 822 |
| Ovid Medline(R) | 2 | 1697 | 1241 |
| Web of Science | 3 | 2107 | 1515 |
| CINAHL | 4 | 101 | 0 |
| TOTAL | 3578 |
Search information in Ovid Embase.
|
| Embase |
|
| Ovid |
|
| 1974 to 6 December 2021 |
|
| 12/07/2021 |
|
| ZJ Zhang |
|
| 829 |
Search information in Ovid Medline(R).
|
| Medline(R) |
|
| Ovid |
|
| 1946 to November Week 4 2021 |
|
| 12/07/2021 |
|
| ZJ Zhang |
|
| 1697 |
Search information in Web of Science.
|
| Web of Science Core |
|
| Web of Science |
|
| 1985 to 2021 |
|
| 12/07/2021 |
|
| ZJ Zhang |
|
| 2107 |
Search information in EBSCO CLNAHL.
|
| CINAHL |
|
| EBSCO |
|
| 1961 to present |
|
| 12/07/2021 |
|
| ZJ Zhang |
|
| 101 |